MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease

Molecular Medicine Reports

Volumn 10, Issue 5, 2014, Pages 2395-2400

  Liu, Chen Geng ^a   Song, Jing ^a   Zhang, Yue Qi ^a   Wang, Pei Chang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Microrna

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; MESSENGER RNA; MICRORNA; MICRORNA 193B; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; MIRN193 MICRORNA, HUMAN; PEPTIDE FRAGMENT;

3' UNTRANSLATED REGION; ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; FEMALE; GENE OVEREXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MILD COGNITIVE IMPAIRMENT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UPREGULATION; AGED; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE;

MUS;

3' UNTRANSLATED REGIONS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BASE SEQUENCE; BINDING SITES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MIDDLE AGED; PEPTIDE FRAGMENTS; RNA INTERFERENCE;

EID: 84907209762     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2484     Document Type: Article

References (30)

1. Lewczuk P, Kamrowski-Kruck H, Peters O, et al: Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry 15: 138-145, 2010.
2. Weiner MW: Dementia in 2012: Further insights into Alzheimer disease pathogenesis. Nat Rev Neurol 2: 65-66, 2013.
3. Singer O, Marr RA, Rockenstein E, et al: Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8: 1343-1349, 2005.
4. Tan L, Yu JT, Hu N and Tan L: Non-coding RNAs in Alzheimer's disease. Mol Neurobiol 47: 382-393, 2013.
5. Junn E and Mouradian MM: MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133: 142-150, 2012.
6. Delay C, Mandemakers W and Hébert SS: MicroRNAs in Alzheimer's disease, Neurobiol Dis 46: 285-290, 2012.
7. Hébert SS and De Strooper B: Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 32: 199-206, 2009.
8. Long JM and Lahiri DK: MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404: 889-895, 2011.
9. Delay C, Calon F, Mathews P and Hébert SS: Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 6: 70, 2011.
10. Hébert SS, Papadopoulou AS, Smith P, et al: Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 19: 3959-3969, 2010.
11. Blennow K, Hampel H, Weiner M and Zetterberg H: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131-144, 2010.
12. Rembach A, Faux NG, Watt AD, et al: AIBL research group, Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimers Dement 10: 53-61, 2014.
13. Lewczuk P, Kamrowski-Kruck H, Peters O, et al: Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry 15: 138-145, 2010.
14. Zetterberg H, Andreasson U, Hansson O, et al: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 65: 1102-1107, 2008.
15. Wang WX, Huang Q, Hu Y, Stromberg AJ and Nelson PT: Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 2: 193-205, 2011.
16. Schonrock N, Ke YD, Humphreys D, et al: Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 5: e11070, 2010.
17. Hosseini HM, Fooladi AA, Nourani MR and Ghanezadeh F: The role of exosomes in infectious diseases. Inflamm Allergy Drug Targets 1: 29-37, 2013.
18. Pant S, Hilton H and Burczynski ME: The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 11: 1484-1494, 2012.
19. Boon RA and Vickers KC: Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 33: 186-192, 2013.
20. Wei PC, Tsai CH, Chiu PS and Lai SC: Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Int J Parasitol 41: 1175-1183, 2011.
21. Wang WX, Rajeev BW and Stromberg AJ: The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 5: 1213-1223, 2008.
22. Liu CG, Xu KQ, Xu X, et al: 17Beta-oestradiol regulates the expression of Na+/K+ -ATPase beta1-subunit, sarcoplasmic reticulum Ca2+-ATPase and carbonic anhydrase iv in H9C2 cells. Clin Exp Pharmacol Physiol 34: 998-1004, 2007.
23. Dassow H and Aigner A: MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr Pharm Des 19: 1242-1252, 2013.
24. Eulalio A, Schulte L and Vogel J: The mammalian microRNA response to bacterial infections. RNA Biol 9: 742-750, 2012.
25. Mitchell PS, Parkin RK, Kroh EM, Fritz BR and Wyman SK: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
26. Giedraitis V, Sundelöf J, Irizarry MC, et al: The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. Neurosci Lett 427: 127-131, 2007.
27. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD and Remaley AT: MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 4: 423-433, 2011.
28. van Leuven F: Single and multiple transgenic mice as models for Alzheimer's disease, Prog. Neurobiol 61: 305-312, 2000.
29. Ceruti S, Colombo L, Magni G, et al: Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem Int 59: 259-271, 2011.
30. Ma R, Jiang T and Kang X: Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 31: 38, 2012.